Postgraduate Medicine 1994: Vol 96 Index

7 Pages·1994·2.8 MB·English

INDEX TO POSTGRADUATE
VOLUME 96 MEDICINE
JULY-DECEMBER 1994
SUBJECTS
ACQUIRED IMMUNODEFICIENCY failures with effective drug treat- ¢ Rationing is secret of health re- DRUGS, ANTIFUNGAL
SYNDROME: See AIDS ment. 96(8):75* form. (ED) 96(1):13 ¢ Regimens for vaginal candidia-
AGING ¢ Why we don’t want a system sis. 96(6):85
¢ Effect of NSAIDs on upper CANCER: See Neoplasms like the British National Health ANTIPLATELET
gastrointestinal tract. 96(6):63"* CARDIOVASCULAR Service. 96(4):67 ¢ For unstable angina. 96(1):93
¢ Nursing home patients with © Carotid artery stenosis, identi- DIABETES © Ticlopidine hydrochloride for
rheumatologic disease, manage- fying candidates for endarterec- © Controlling harmful effects of stroke prevention after transient
ment. 96(2):91* tomy. 96(5):61* hypertension with lifestyle modifi- ischemic attacks. 96(5):48
AGORAPHOBIA © Cerebrovascular, management cations and pharmacologic ther- ANTIRHEUMATIC
* Diagnosis and treatment. 96(1): of acute stroke to minimize dam- apy. 96(6):101* © For juvenile rheumatoid arthri-
125 age and maximize recovery. 96(5): ¢ Effect of exercise. (PN) 96(3):134 tis. 96(2):83
AIDS ¢ Foot ulcers, prevention and DRUGS, BETA BLOCKER
¢ HIV infection, oral and derma- © Cerebrovascular, signs of stroke. management to avoid amputation. e Effect on diabetes and hyper-
tologic manifestations, diagnosis (PN) 96(5):214* 96(5):177* tension. 96(6):109
and treatment. 96(5):105* © Congestive heart failure, exer- ¢ Ketoacidosis, clinical presenta- ¢ For congestive heart failure.
AIRWAY OBSTRUCTION cise training, achieving benefits tion, components of therapy, and 96(5):170
© Obstructive sleep apnea, rec- safely. 96(2):119* follow-up. 96(3):75* ¢ For unstable angina. 96(1):92
ognition and treatment, medical © Congestive heart failure, over- © Type |, intensified insulin regi- CALCIUM ANTAGONIST
and surgical approaches to man- view, pharmacologic therapy and mens, when to use. 96(3):63* ¢ For unstable angina. 96(1):93
agement. 96(3):115* surgical techniques to decrease © Type |, pancreas transplanta- DRUGS, CALCIUM CHANNEL
ALCOHOLISM mortality. 96(5):167* tion—weighing benefits, risks, BLOCKER
e Alcoholic hepatitis, recent ad- ¢ Effect of estrogen replacement and costs. 96(3):105* e Effect on diabetes and hyper-
vances in pathogenesis, pros therapy at menopause. 96(5):133 DIAGNOSTIC TECHNIQUES tension. 96(6):109
and cons of current medical and © Hypertension in diabetic patient, e In evaluating euthyroid patient DRUGS, CORTICOSTEROID
surgical treatment. 96(8):61* controlling its harmful effects with with elevated thyroxine levels. (CR) © For alcoholic hepatitis. 96(8):68
ANAPHYLAXIS lifestyle modifications and phar- 96(5):195 © For juvenile rheumatoid arthritis.
© During treatment of snakebite macologic therapy. 96(6):101* ¢ Polysomnography in diagnosis 96(2):83
envenomation. 96(1):109, 112 ¢ Risk factors, which can be of obstructive sleep apnea. 96(3): DRUGS, DIURETIC
ANEMIA remedied? 96(3):49" 6 ¢ Effect on diabetes and hyper-
* Hemolytic, in sickle cell disease. © Thrombolysis after acute myo- * Sigmoidoscopy. (PN) 96(6):134 tension. 96(6):108
96(8):107 cardial infarction, current indica- DIARRHEA © For congestive heart failure.
: See Drugs, antibiotic tions and contraindications. 96(8): ¢ Acute and chronic, systematic 96(5):170
ANXIETY 30* approach to laboratory testing. DRUGS, HISTAMINE, BLOCKER
¢ Phobias and irrational fears, © Thrombolysis after acute myo- 96(3):30* © For peptic ulcer disease. 96(6):
helping patients overcome them. cardial infarction, summary of clin- DIET: See Nutrition 54
96(1):125* ical trials on adjuvants to throm- DRUG THERAPY DRUGS, HORMONE
ARTHRITIS: See Rheumatic dis- bolysis. 96(8):45* ¢ For unstable angina. 96(1):90 e Estrogen replacement therapy
eases © Transient ischemic attacks, DRUGS, ACE INHIBITOR at menopause, benefits outweigh
evaluation of risk for stroke or e Effect on diabetes and hyper- risks. 96(5):131*
BEHAVIORAL MEDICINE myocardial infarction. 96(5):42* tension. 96(6):109 DRUGS, IMMUNOSUPPRESSIVE
¢ For obsessive-compulsive dis- e Unstable angina, drug therapy © Nitrate-induced methemoglo- ¢ For juvenile rheumatoid arthri-
order. 96(8):122 versus invasive therapy. 96(1):88* binemia. (CR) 96(3):124 tis. 96(2):84
BIOPSY ¢ Vascular complications in feet ADVERSE REACTIONS INOTROPIC
© Liver, in determining cause and of diabetic patients, prevention ¢ Meningitis, drug-induced, clini- * ‘Digoxin in symptomatic con-
severity of liver damage. 96(8):63 and management to avoid ampu- cal presentation and course of gestive heart failure. 96(5):169
BITES AND STINGS tation. 96(5):178 disorder. (CR) 96(6):117 DRUGS, NONSTEROIDAL
¢ Rattlesnake bites, guidelines for COLONIC DISEASES: See Gastro- ¢ Nitrate-induced methemoglo- ANTI-INFLAMMATORY (NSAIDs)
aggressive treatment. 96(1):107* intestinal diseases binemia. (CR) 96(3):124 © Effect on upper gastrointestinal
BLOOD COLONOSCOPY , ANTIANGINAL tract. 96(6):63*
* Transfusions in management © In screening for colorectal can- ¢ Nitroglycerin for unstable an- © For juvenile rheumatoid arthri-
of sickle cell disease. 96(8):114 cer. 96(1):103 gina. 96(1):90 tis. 96(2):79
BLOOD GLUCOSE D ANTIBIOTIC e Use in nursing home patients,
¢ Achieving control in type | dia- DELIVERY OF HEALTHCARE ¢ Cause of diarrhea. 96(3):37 alternatives. 96(2):95
betes, when to use intensified in- ¢ Can managed care work? 96(4): ¢ For acute bacterial exacerba- PROTON
sulin regimens. 96(3):63* 55 tions of chronic bronchitis. 96(8):76 © Omeprazole for acid reduction
© Follow-up after treatment of e Effects of healthcare reform on ¢ For Helicobacter pylori infection. in peptic ulcer disease. 96(6):56
diabetic ketoacidosis. 96(3):88 practicing physicians. 96(7):29 96(6):42 DRUGS, THROMBOLYTIC
BRONCHITIS ¢ “Government-guaranteed” ¢ For treatment and prevention e Adjuvants to thrombolysis after
* Chronic, acute bacterial exac- healthcare coverage may unleash of infectious vaginitis. 96(6):85 acute myocardial infarction, clini-
erbations, preventing treatment litigation explosion. 96(7):91 © Trimethoprim-sulfamethoxa- cal trials, summary of findings.
© Healthcare compromises could zole, cause of meningitis. (CR) 96(8):45*
change practice of medicine in 96(6):117 ¢ For unstable angina. 96(1):95
*Major clinical discussion US. (ED) 96(4):11 DRUGS, ANTICOAGULANT ¢ Studies on effectiveness after
CR, Case Report ¢ Problems with current system, * Complicated by skin necrosis. acute myocardial infarction. 96(8):
ED, Editorial solutions for reform. 96(7):47 96(8):99 30
PH, Physician-at Large * Quality of US healthcare—will DRUGS, ANTIDEPRESSANT DRUGS, VASODILATOR
PN, Patient Notes it survive? 96(4):61 © For obsessive-compulsive dis- ¢ For congestive heart failure.
order. 96(8):120 96(5):170
continued on page 134
VOL 96/NO 8/DECEMBER 1994/POSTGRADUATE MEDICINE 131
SEAL MART OAR RES OR
INDEX TO VOLUME 96 CONTINUED
58H2iH72 33
The twice-daily regimen of Ismo tablets successtully avoided significant rebound/withdrawal effects in ;
fern itrates, incidence and magnitude of such phenomena appear tob e highty dependent upon the schedule
are extrrearem, beut ldoy occ ur. Ismo ts contraiinnp adtiientcs aalltergeic dto i t
Because the effects of Ismo are difficult tot erminate and have not been established in patients with
myocardial intarction (Mi) or congestive heart failure (CHF),
used in these patients. careful clinical or hemodynamic
pallens wheo y’b ev olume Gapleied ori hea xa iveady Paradoxical and increased
accompany Ismo-induced hypotension .
angina caused by hypertrophic cardiomyopathy.
follow the prescribed dosing schedule (2 doses taken 7 hours apart) tom aintain the EAR DISEASES © Helicobacter pylori infection
dose on awakening and second dose 7 hours later). ¢ Middle ear symptoms—baro- in patients with recurrent ulcers,
sometimes ’ ' ing Ismo, and are a marker ofd rug activity. trauma—in airline passengers, current issues and treatment.
sPimualtantewoiuist h lehoesasdn aochfte s ssho uld not alter tHheeiard tachrese amayts cbhmeede utlrnee atsteidn cwei th asopfir ihne aadnadc/hoer maacyet bamei anospsheonc iwaitthewoidut th causes, treatment, and prevention. 96(6):40*
affecting the antianactgiviityn oafI lsm o 96(2):135* © Hepatitis, alcoholic, recent ad-
-heaond staendindg, enspeceiallsy jusst a fter from a recumbent or seated position, may occur. This may © Otitis externa and bullous myr- vances in pathogenesis and ther-
be more frequent inp atients who have consumed ingitis, diagnosis and treatment by apy. 96(8):61*
primary care physicians. 96(5):141* ¢ Hereditary hemochromatosis,
ELDERLY: See Aging diagnosis and treatment. 96(5):
EMERGENCY MEDICINE 151°
® Calling 911. (PN) 96(8):154 GENETIC DISORDERS: See He-
oral smo, nor were adverse effects on rat fertility * Dermatologic emergencies, reditary diseases
recognition and treatment. 96(1): GENITAL
¢ Infectious vaginitis, selecting
to have embryocidal effects inr ats and rabbits atd oses at least 70 times the maximum human ¢ Rattlesnake bites, guidelines therapy and preventing recurrence.
ee ree ee Use during pregnancy only if potential for aggressive treatment. 96(1): 96(6):85*
MOTHERS 107" GERIATRICS: See Aging
Excirnh uemant miilk iosu nnkno wn. Use caution ifa dminitosa tn uresirnge wodma n ¢ Transient ischemic attacks, ur- GYNECOLOGY: See Obstetrics/
PEDIATRIUCS E gent evaluation of risk for stroke Gynecology
ASadfveetrys ea nRd eeacftiofnse chtavie nvot ebeenn eestsablsish ed or myocardial infarction. 96(5):42*
ENDOCRINE DISORDERS HEALTH POLICY
e Diabetes: See Diabetes ¢ AMA and other medical organi-
© Elevated thyroxine levels in eu- zations, time for changes. (ED)
thyroid patient. (CR) 96(5):195
¢ Pituitary and hypothalamic ab- ° British National Health Service
normalities in chronic fatigue syn- —not for Americans. 96(4):67
drome, current findings. 96(6):76 ¢ Can managed care work? 96(4):
EQUIPMENT 55
following (in many cases a causal relationship !s uncertain): Cardio- © Left ventricular assist devices © Differing views on healthcare
for congestive heart failure. 96(5): for everyone. 96(4):31
I! i ic; jptrouurriitnuasr,y ,r asdhy.s uGraisat,r oiinmtpeostteinncael,; 170 © Effect of healthcare reform on
EXERCISE quality of US healthcare. 96(4):61
gic; agitation, anxiety, sion, dyscoordination, hypoesthesia, ¢ Aerobic conditioning in children ¢ Effects of healthcare reform on
. high spiratory; bronchitis, pneumonia, upper with juvenile rheumatoid arthritis. practicing physicians. 96(7):29
q a doses of organic nitrates have caused methemogiobinemia in normal-seeming patients (See 96(2):84 © Healthcare legislation fails
¢ Patients with diabetes. (PN) thanks to congressional gridlock.
96(3):134 (ED) 96(7):11
Fcoarodina c ocuutpmuttn aented hyopomte ngsimona. t Sysmipttoemds t omSa ye i nictluede o itntc roenasee td ei dnatsre acrprH aesnsuirea,. lwi th or at © Training in patients with con- © Healthcare reform, helping phy-
headache, gestive heart failure, achieving sicians survive reform process.
vomiting even bloody diarrhea): syncope emeely posture)a:i r benefits safely. 96(2):119* 96(7):61
Syepnes, ert ole a; pnda renaicioalmea:r yys ecishzuortiets dasneda; tdeo antahe he hane tter lonlod orc oldt adc lamanp ¢ Healthcare reform requires tort
have no role in managing overdose. The likely lethal dose in humans is unknown. FOOT DISEASES reform—a physician-lawyer dia-
isn either a speci . Ror ing itse liminatitorno m ¢ Ulcers in diabetic patients, pre- logue. 96(4):45
: di 3 Is . direicvte t.h erapy toward aasns oicnciraetaesde inwith cenItsrmaol fluid volumree.s uUlstes of arteriai vasocioonns tarndi carttoe(rriesagl , vention and management to avoid ¢ Healthcare reform wars, prob-
epinephrine) is likely to do more harm than good. In patients with renal disease or CHF, treatment of Ismo overdose amputation. 96(5):177* lems in current system and solu-
may be and require invasive FUNGAL DISEASES tions for reform. 96(7):47
<a fitirant eass,s ocainadt iporno vwaibtlhy mcooduelrda toec couvre radsos ae ss iodfe ¢ Fungal otitis externa, diagnosis ¢ How changes in Congress
and treatment by primary care might affect healthcare reform
deliSey bverroyw nd,ie swpiibttheo ueatd ec qoulaotre cchangae o onue texptpuotts ua rne dt oe air.a The treeatmgent : physician. 96(5):142 proposals in 1995. (ED) 96(5):13
is methylene biue, 1-2 mg/kg intravenously. ¢ In HIV-infected patients, diag- ¢ Inefficiency in government-
nosis and treatment. 96(5):108 controlled healthcare. (ED) 96(3):15
¢ Last-minute deal making for
GASTROINTESTINAL DISEASES health reform. (ED) 96(4):11
© Acid reduction in peptic ulcer ¢ Problems with standard benefit
disease, choosing appropriate package proposed in health re-
drug therapy. 96(6):53* form bill. (ED) 96(2):11
, large controlled studies with other nitrates © Colorectal cancer, current rec- * Rationing is secret of health re-
be expected to provide more than 12 hours of continuous antianginal efficacy per ommendations for screening. form. (ED) 96(1):13
TDhoissa gBer iaedfj Suustmmmeanrtys iasr eb ansoetd n eucpeosns atrhye icunr trhenet e lIdsemrloy dpiarteicetnitosn ocrir icnul oaart,i eCnlt s4 1w3i0t-h2 a,l tReerveid sreedn aOlc toorb heerp a2t0i,c 1f9u9n2c tion 9¢ 6(C1o):m9p9l*i cations from use of s¢ icRiaenf ocromm pfernosma tviioenw.p oi9n6t( 7o)f: 7p3h y-
References: 1. Thadani U, Maranda CR, Amsterdam E, et al: Lack of phar- NSAIDs. 96(6):63* ¢ Reform may result in increased
© Diarrhea, acute and chronic, litigation. 96(7):91
macologic tolerance and rebound angina pectoris during twice-daily therapy systematic approach to laboratory ¢ What AAFP leaders say on
with isosorbide-5-mononitrate. Ann intern Med 1994;120:353-359. testing. 96(3):30* health reform. (ED) 96(6):15
2. Friedman RG, et al: Comparative clinical trial of isosorbide mononitrate ¢ Examination using sigmoidos- HEART DISEASE: See Cardiovas-
and isosorbide dinitrate in patients with stable angina pectoris. J \nvas copy. (PN) 96(6):134 cular diseases
Cardiol 1992;4:319-329.
A OBINS SORINGER “a y q LWAYBEOTRHA-TAOYREIRESST
AR a i VOL 96/NO 8/DECEMBER 1994/POSTGRADUATE MEDICINE
©1994, Wyeth-Ayerst Laboratories 60402
HEMATOLOGIC DISEASES © Skin, identification and manage- MENINGITIS © Otitis externa and bullous myr-
¢ Amyloidosis, clinical presenta- ment. 96(2):43 ¢ Drug-induced, clinical presen- ingitis, treatment without referral
tions and disease associations. © Toxic shock syndrome, criteria tation and course of disorder. (CR) to specialist. 96(5):141*
96(5):119* for diagnosis, treatment. 96(1):73 96(6):117
© Hereditary hemochromatosis, INSULIN METABOLIC DISORDERS PAIN
diagnosis and treatment. 96(5): e Diabetic ketoacidosis, avoiding © Diabetic ketoacidosis, avoiding * Crisis in sickle cell disease,
complications with appropriate complications with appropriate management. 96(8):107
* Methemoglobinemia, case of treatment strategies. 96(3):75* treatment strategies. 96(3):75* e Joints, in nursing home pa-
nitrate-induced. (CR) 96(3):124 e Intensified regimens in type | MOUTH DISEASES tients, management. 96(2):91*
* Sickle cell disease, manage- diabetes, when to use. 96(3):63" © Oral manifestations of HIV in- e Juvenile rheumatoid arthritis,
ment of complications, psycho- INSURANCE, HEALTH fection, diagnosis and treatment. overview. 96(2):84
social impact. 96(8):107* © Problems with standard benefit 96(5):105* ¢ Myofascial pain syndrome,
HEPATITIS package proposed in health re- MUSCULOSKELETAL DISORDERS clinical evaluation and treatment.
¢ Alcoholic, recent advances in form. (ED) 96(2):11 ¢ Muscle cramps. (PN) 96(1):155
pathogenesis, pros and cons of IRON ¢ Myofascial pain syndrome, PATIENT EDUCATION
current medical and surgical man- ¢ Hemochromatosis, hereditary, clinical evaluation and treatment. © Calling 911. (PN) 96(8):154
agement. 96(8):61* detection and correction. 96(5): 96(2):56* ¢ Exercise and diabetes. (PN)
° — information. (PN) 96(2): ¢ Osteoporosis, effect of estro- 96(3):134
15) gen replacement therapy at meno- © Hepatitis. (PN) 96(2):150
HEREDITARY DISEASES JOINTS pause. 96(5):132 ¢ Muscle cramps. (PN) 96(1):155
* Hemochromatosis, diagnosis e Pain, rheumatologic disease in © Sigmoidoscopy. (PN) 96(6):134
and treatment. 96(5):151* nursing home patients, manage- NEOPLASMS © Stroke. (PN) 96(5):214
HORMONES ment. 96(2):91* © Colorectal cancer, current rec- PEDIATRICS
¢ Estrogen replacement therapy ommendations for screening. e Juvenile rheumatoid arthritis,
at menopause, benefits outweigh KIDNEY DISEASES 96(1):99" overview. 96(2):75*
risks. 96(5):131* ¢ Acute renal failure, clinical and ¢ Neoplastic lesions associated © Middle ear blocks during air
HYPERTENSION: See Cardiovas- laboratory evaluation and appro- with HIV infection, diagnosis and travel, prevention. 96(2):141
cular diseases priate management. 96(5):89* treatment. 96(5):111 ¢ Sickle cell disease, clinical
NEUROLOGIC MANIFESTATIONS manifestations. 96(8):113
IMMUNOLOGIC DISEASES LABORATORY INVESTIGATION © Meningitis, drug-induced, clini- PHYSICIANS
¢ Amyloidosis, clinical presenta- e Elevated thyroxine levels in eu- cal presentation and course of * Compensation, effects of
tions and disease associations. thyroid patient, diagnostic ap- disorder. (CR) 96(6):117 healthcare reform. 96(7):73
96(5):119* proach. (CR) 96(5):195 ¢ Neurotransmitter abnormalities © Medical organizations need to
© Chronic fatigue syndrome, im- © Fecal occult blood testing. in chronic fatigue syndrome, cur- make changes. (ED) 96(8):13
plications of new findings. 96(6): 96(1):100 rent findings. 96(6):76 ¢ Surviving healthcare reform.
73* ¢ For hemochromatosis. 96(5): © Stroke. (PN) 96(5):214 :61
INCONTINENCE 155 © Stroke, acute, features and cur- ° Thoughts on effects of health-
© Urinary, in women, review of © Histologic tests for Helicobac- rent therapy. 96(5):75* care reform. 96(7):29
diagnostic tests and manage- ter pylori infection. 96(6):42 ¢ Transient ischemic attacks, op- POISONING
ment options. 96(2):103* ¢ In alcoholic hepatitis. 96(8):64 timal management to prevent e Rattlesnake bites, guidelines
INFECTION * In patients with chronic diar- stroke. 96(5):42* for aggressive treatment. 96(1):
© Acute infectious diarrhea, diag- rhea. 96(3):38, 43 NURSING HOMES 107*
nosis. 96(3):35 LEG e Patients with rheumatologic POLYPS
¢ Annular skin eruptions, diag- ¢ Muscle cramps. (PN) 96(1):155 disease, management. 96(2):91* © Colorectal, detection through
nosis and treatment. 96(1):37* LIVER DISEASES NUTRITION screening for colorectal cancer.
¢ Bacterial exacerbations of ¢ Alcoholic hepatitis, recent ad- ¢ Diet modification and weight 96(1):99
chronic bronchitis, preventing vances in pathogenesis, pros and reduction to control hypertension PSYCHIATRIC/PSYCHOSOCIAL
treatment failures through effec- cons of current medical and sur- in patient with diabetes. 96(6):108 DISORDERS
tive drug treatment. 96(8):75* gical management. 96(8):61* ¢ Nutritional support in alcoholic © Obsessive-compulsive disor-
© Bacterial sepsis in children with © Hepatitis. (PN) 96(2):150 hepatitis. 96(8):68 der, clinical presentations, phar-
sickle cell disease. 96(8):113 ¢ Hereditary hemochromatosis, ¢ Role of malnutrition in alcoholic macologic and behavior therapy.
© Foot ulcers in patients with di- diagnosis and treatment. 96(5): hepatitis. 96(8):61 96(8):119*
abetes, prevention and manage- ¢ Phobias, diagnosis and treat-
ment to avoid amputation. 96(5): OBSTETRICS/GYNECOLOGY ment. 96(1):125*
MALPRACTICE ¢ Estrogen replacement therapy ¢ Psychosocial impact of sickle
* Helicobacter pylori, role in pa- e Increased litigation, real possi- at menopause, benefits outweigh cell disease. 96(8):115
tients with recurrent ulcers and bility with healthcare reform. 96(7): risks. 96(5):131*
treatment. 96(6):40* 91 ¢ Female urinary incontinence, RECTAL DISEASES
© Hepatitis. (PN) 96(2):150 © Tort reform goals in healthcare review of diagnostic tests and © Colorectal cancer, current rec-
¢ HIV, oral and dermatologic reform. 96(4):45 management options. 96(2):103* ommendations for screening.
manifestations, diagnosis and MEDICAL PRACTICE ¢ Infectious vaginitis, selecting 96(1):99*
treatment. 96(5):105* ¢ Managed care—can it work? therapy and preventing recur- RENAL FAILURE: See Kidney dis-
¢ Infectious vaginitis, selecting 96(4):55 rence. 96(6):85* eases
therapy and preventing recurrence. e Physician compensation, ef- RESPIRATORY DISEASES
96(6):85* fects of healthcare reform. 96(7): DISEASES * Chronic bronchitis, acute bac-
¢ Lyme disease, cutaneous 73 ¢ Middle ear symptoms in airline terial exacerbations, preventing
manifestations. 96(8):96 © Surviving healthcare reform, passengers, causes, treatment, treatment failures. 96(8):75*
tips for physicians. 96(7):61 and prevention. 96(2):135* continued on page 139
VOL 96/NO 8/DECEMBER 1994/POSTGRADUATE MEDICINE
LeeS ee SN
ee»
INDEX TO VOLUME 96 CONTINUED
¢ Obstructive sleep apnea, rec- © Carotid endarterectomy for UROLOGIC DISEASES VASCULAR : See Car-
ognition and treatment. 96(3):115* stroke prevention. 96(5):47 ¢ Acute renal failure, prompt di- diovascular diseases
RHEUMATIC DISEASES ¢ Endarterectomy, to reduce in- agnosis key to effective manage- VENEREAL DISEASES: See Sexu-
¢ Arthritis and associated amy- cidence of stroke in patients with ment. 96(5):89" ally transmitted diseases
loidosis, as and treatment. carotid artery stenosis. 96(5):61 e Urinary incontinence in women, VIRAL DISEASES
96(5):119 ¢ For urinary incontinence in review of diagnostic tests and ¢ Hepatitis. (PN) 96(2):150
e Juvenile eee arthritis, women. 96(2):105 management options. 96(2):103*
overview. 96(2):75 ¢ Liver transplantation for end-
¢ Lyme disease, cutaneous mani- stage alcoholic liver disease.
festations. 96(8):96 96(8):69
¢ Rheumatologic disease in nurs- ¢ Myringotomy for ear block in
oerh ome patients, management. airline passengers. 96(2):141
e Pancreas transplantation for
type | diabetes, weighing bene-
SCREENING fits, risks, and costs. 96(3):105*
¢ For colon cancer using sigmoi-
doscopy. (PN) 96(6):134 THERAPEUTICS
¢ For colorectal cancer, current ¢ Coronary angioplasty as ad- AUTHORS
recommendations. 96(1):99* junct to thrombolysis after acute
¢ For hereditary hemochromato- myocardial infarction. 96(8):47
sis. 96(5):158 + a diabetic ketoacidosis. 96(3):
SEXUALLY TRANSMITTED ABOUSSOUANLS BRAITH RW
DISEASES e For myofascial pain syndrome. Obstructive sleep apnea: Ward- Exercise training in patients
© Trichomoniasis, recognition 96(2):63 ing off the sometimes dire conse- with heart failure:
and treatment. 96(6):91 ¢ intra-aortic balloon pump for quences. 96(3):115 How to achieve benefits safely.
SIGMOIDOSCOPY congestive heart failure. 96(5):170 ALLEN SH 96(2):119
¢ In screening for colorectal can- ¢ Nonsurgical treatment of female See oe |G T BRECHTELSBAUER DA
cer. 96(1):103 urinary incontinence. 96(2):106 AMIDONT M Managing rheumatologic dis-
SKIN DISEASES ¢ Phlebotomy therapy for hemo- See Figueredo VM ease in nursing home patients.
¢ Annular skin eruptions, diag- chromatosis. 96(5):157 96(2):91
nosis and treatment. 96(1):37* ¢ Thrombolysis after acute myo- ANDERSON EG BRONOW R
© Blistering disorders, causes, rec- cardial infarction, current indica- The British are coming! The Will the quality of US health-
ognition, and treatment. 96(1):53* tions and contraindications. 96(8): British are coming! 96(4):67 care survive?: A physician's per-
* Common infections, character- A lifetime of half-truths. (PH) spective. 96(4):61
istics, causes, and cures. 96(2):43* THYROID DISEASES 5))::1 9 BROWN TP
¢ Dermatologic emergencies, rec- ¢ Euthyroid hyperthyroxinemia, On (holiday) call. (PH) 96(8):21 Middle ear symptoms while fly-
ognition and treatment. 96(1):67* diagnostic approach and over- These were a few of my favor- ing: Ways to prevent a severe
¢ Dermatologic manifestations of view of normal thyroid physiol- ite things. (PH) 96(6):27 outcome. 96(2):135
HIV infection, diagnosis and treat- ogy. (CR) 96(5):195 Words from the worldly. (PH) BURDICK E
ment. 96(5):105* TRANSPLANTATION 219 Sickle cell disease: Still a man-
© Signs of systemic disease, rec- © Bone marrow in sickle cell dis- agement challenge. 96(8):107
ognition and treatment. 96(8):93* ease. 96(8):114 Helicobacter pylori infection:
SLEEP DISORDERS © Cardiac, criteria, contraindica- When and in whom is treatment CARR AA
* Obstructive sleep apnea, rec- tions. 96(5):171 important? 96(6):40 See Prisant LM
ognition and treatment, medical ¢ Liver, for end-stage alcoholic CHATURVEDI S
and surgical approaches to man- liver disease. 96(8):69 BACON BR Transient ischemic attacks:
agement. 96(3):115* ¢ Pancreas, for type | diabetes See Olynyk JK Rethinking concepts in manage-
SPLENIC DISEASES mellitus, weighing benefits, risks, BART BJ ment. 96(5):42
¢ Autosplenectomy in children and costs. 96(3):105* Annular skin eruptions: Not ev- CLINE MS
with sickle cell disease. 96(8):113 TRAUMA ery ring on the skin is ringworm. Curing the ‘nitrate blues.’ (CR)
* Splenic sequestration crisis in e Myofascial pain syndrome, 96(1):37 96(3):124
children with sickle cell disease. Clinical evaluation and treatment. BELL DS CZERSKA B
96(8):113 Chronic fatigue syndrome up- See Hobbs RE
STROKE * Rattlesnake bites, guidelines for date: Findings now point to CNS
¢ Acute, management to mini- aggressive treatment. 96(1):107* involvement. 96(6):73 DAVDA RK
mize damage and maximize re- BERENSON RA Acute renal failure: Prompt di-
covery. 96(5):75* CER Can a managed care market agnosis is key to effective man-
© Patient information. (PN) 96(5): b. y by NSAID use, popu- work?: It’s time for physicians to agement. 96(5):89
14 lations at risk and potential solu- ‘get real.’ 96(4):55 DAVIDSON TM
¢ Reducing incidence with en- tions. 96(6):63* BIEDLINGMAIER JF Rattlesnake bites: Guidelines for
darterectomy in patients with © Foot, in diabetic patients, pre- Two ear problems you may not aggressive treatment. 96(1):107
carotid artery stenosis. 96(5):61* vention and management to need to refer: Otitis externa and DAVILA GW
¢ Risk for after transient ischemic avoid amputation. 96(5):177* bullous myringitis. 96(5):141 Urinary incontinence in wom-
attacks, need for urgent evalua- e Peptic, choosing _— BLUMENREICH PE en: How to help patients regain
tion to prevent stroke. 96(5):42* drug therapy. 96(6):53 Phobias: How to help patients bladder control. 96(2):103
SURGERY ¢ Recurrent, role of Helicobacter overcome irrational fears. 96(1):125 DUCKWORTH WC
* Cardiac transplantation, crite- pylori infection, current issues and BOTTINI PB See Larsen JL
ria, contraindications. 96(5):171 treatment. 96(6):40* See Prisant LM continued
VOL 96/NO 8/DECEMBER 1994/POSTGRADUATE MEDICINE
INDEX TO VOLUME 96 CONTINUED
EDMEADSJ G GUMS JG McCANDLESS HC SHENAQ SM
Stroke. (PN) 96(5):214 See Goode MA A survival kit for physicians: How to help diabetic
EL-NEWIHIH M GUZMAN NJ Back to the basics. 96(7):61 avoid am : Prevention
Alcoholic hepatitis: Recent ad- See Davda RK McCLAFLIN RR and management of foot ulcers.
vances in pathogenesis and ther- Myofascial pain syndrome: Pri- 96(5):177
apy. 96(8):61 HACHINSKI V mary care strategies for early in- SMITH BA
ELLIOTT WJ See Chaturvedi S tervention. 96(2):56
Cardiovascular risk factors: HACKER SM MARSHALL JB
Which ones can and should be Common infections of the skin: Sigmoidoscopy. (PN) 96(6):134
remedied? 96(3):49 Characteristics, causes, and cures. MASSA MC
See Holmes CE
FIGUEREDO VM MIHAS AA
Adjuvants to thrombolysis after See El-Newihi HM
acute myocardial infarction: MILLS RM Jr
Does adding antiplatelet agents, Use of NSAIDs: An assault on the See Braith RW
antithrombotics, or angioplasty upper gastrointestinal tract. 96(6): MOFFIT RE
make a difference? 96(8):45 63 Healthcare reform wars: Some-
Thrombolysis after acute myo- HOBBS RE body could get hurt. 96(7):47
cardial infarction: Who should heart failure: Current MURRAY JA
be added to inclusion criteria? and future strat a to decrease See Talal AH
96(8):30 mortality. 96(5):1 to keep eyed testing toa
FISH LH HOLLANDERP OLSON CL minimum. 96(3):30
Diabetic ketoacidosis: Treat- eee: CSN Blistering disorders: a ones TIBBITTS GM
ment strategies to avoid compli- can be deadly? 96(1):53 Juvenile rheumatoid arthritis:
cations. 96(3):75 intensified insulin regimens: OLYNYK JK Old challenges, new insights.
Should they be used in all patients Hereditary hemochromatosis: 96(2):75
GANNON T : with type | diabetes? 96(3):63 Detecting and correcting iron over- TOBIAS CR
Dermatologic emergencies: HOLMES CE load. 96(5):151 See Pary R
When early recognition can be Skin signs of systemic disease:
lifesaving. 96(1):67 When the problem is more than PAAT JJ UY HL
GOLISH JA skin-deep. 96(8):93 See Wong JG Elevated thyroxine levels in a
See Aboussouan LS HOUGHTON JL PARENT K euthyroid patient: A search for
GOODE MA See Prisant LM Acid reduction in peptic ulcer the cause of euthyroid hyperthy-
Infectious vaginitis: Selecting disease: Choosing therapy ac- roxinemia. (CR) 96(5):195
therapy and preventing recurrence. ISMAIL HM cording to drug interactions, indi-
96(6):85 See Verghese A vidual response, and cost. 96(6):53 VARGO D
GRAUER K — Rr See Shenaq SM
See Goode MA JAIGOBIN CS disorder: VERGHESE A
GRIFFIN GC Carotid artery stenosis: Select- hom to free re a = intrusive Acute exacerbations of chronic
Calling 911. (PN) 96(8):154 ing candidates for surgical man- thoughts and rituals. 96(8):119 bronchitis: Preventing treatment
Consensus?: Maybe—but fast agement. 96(5):61 PATERSON RW _ and early reinfection. 96(8):
deal makin: could cause a disas- JEWELL ME See Wong JG
ter. (ED) 4):11 Oral and dermatologic manifes- PERRY JR VOGELGESANG SA
The dirty heaith re- tations of HIV infection. 96(5):105 See Jaigobin CS The many guises of amyloido-
form: ‘it’s rationing, stupid!’ (ED) POLLACK B sis: Clinical presentations and
96(1):13 KALLURU VB the patient have HIV? I disease associations. 96(5):119
Medicare sends doctor 1-cent See Kochar MS can’t tell. (PH) 96(3):19
check! (ED) 96(3):15 KLEBUC MJA PRISANT LM BJ
Now, time for some changes at See Shenaq SM Unstable angina: Pharmaceutical The doorman at hotel HMO.
AMA? (ED) 96(8):13 KLIPPLE GL versus invasive therapy. 96(1):88 (PH) 96(1):23
A skunk in gift wrapping: Alias, See Vogelgesang SA PRYSE-PHILLIPSW WOLFE cL
a standard benefit package. (ED) KOCHAR MS Management of acute stroke: See Figueredo VM
96(2):11 Hypertension in the diabetic Ways to minimize damage and WONG JG
Some medical leaders still don’t patient: Controlling its harmful maximize recovery. 96(5):75 Drug-induced meningitis: A
it! (ED) 96(6):15 effects. 96(6):101 case involving trimethoprim-
ks to our country’s foun- REASNECAR ll sulfamethoxazole. (CR) 96(6):117
ders for inventing gridlock! (ED) LARSEN JL SeUey HL WOOD BG
96(7):11 Pancreas transplantation for ROBERTS WO See Aboussouan LS
Will Congress change hands?: type | diabetes mellitus: Do the Muscle cramps. (PN) 96(1):155
Preposterous! Outrageous! Pos- benefits offset the risks and cost? RODEGHERO JA YEGAPPAN MC
sible! (ED) 96(5):13 96(3):105 Who, me? An employee?: The See Pryse-Phillips W
See also Roberts WO; Stack P LIPPMANN SB changing schemes of physician
GRIFFING GT See Blumenieich C; Pay FR compensation. 96(7):73
therapy LUSH DT
at menopause: How benefits Screening for colorectal can- SCHAFER SF
outweigh risks. 96(5):131 cer: Use of a new protocol may See Davidson TM
reduce death rates. 96(1):99
VOL 96/NO 8/DECEMBER 1994/POSTGRADUATE MEDICINE